IBIO vs WTW · rev $100.0K vs P/E 15, rev $4.88B
iBio, Inc. Common Stock (IBIO) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Latest reported WTW revenue for 2026-06-30 was $4.88B. Net income was $526.0M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
IBIO currently screens at market cap $13.4M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the IBIO and WTW stock pages for the full models.
Not investment advice.